Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho guanine nucleotide exchange factor 18 (ARHGEF18) is an enzyme that functions as a guanine nucleotide exchange factor (GEF) for RhoA and RAC1 GTPases, thereby regulating the switch from the inactive GDP-bound form to the active GTP-bound form in these small G proteins. It plays a crucial role in the organization of the actin cytoskeleton, formation of actin stress fibers, tight junction assembly, and maintenance of epithelial barrier function. It also participates in intracellular signaling pathways including transcription regulation, cell growth, motility, and, under specific conditions such as viral infection, immune response activation through the NF-κB pathway. Dysregulation or mutation of ARHGEF18 has been associated with diseases such as retinitis pigmentosa and may be implicated in cancer and other cytoskeleton-related cellular disorders.
Guanine nucleotide exchange factor activity (activates RhoA, and RAC1 by facilitating GDP-GTP exchange); Modulation of actin stress fiber formation and reactive oxygen species (for RAC1); Activation of NF-κB pathway through protein–protein interaction in viral infection context
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho guanine nucleotide exchange factor 18 (ARHGEF18).